The Scientist

» techniques, disease/medicine and immunology

Most Recent

image: Characterizing the Imprintome

Characterizing the Imprintome

By | January 1, 2017

Three techniques for identifying the collection of maternal and paternal genes silenced in offspring

3 Comments

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

A test tube-based genome-labeling technique has been brought under the microscope.

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: Top Technical Advances 2016

Top Technical Advances 2016

By | December 15, 2016

The year’s most impressive achievements include methods to watch translation in cells, trace cell fates, avoid mitochondrial mutations, edit DNA, and build antibiotics from scratch.

0 Comments

image: Naive T Cells Find Homes in Lymphoid Tissue

Naive T Cells Find Homes in Lymphoid Tissue

By | December 2, 2016

The human lymph nodes and spleen maintain unique, compartmentalized sets of naive T cells well into old age.

0 Comments

image: How to Track Cell Lineages As They Develop

How to Track Cell Lineages As They Develop

By | December 1, 2016

Sequencing and gene-editing advances make tracing a cells journey throughout development easier than ever.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. An Aging-Related Effect on the Circadian Clock
  2. Marching for Science, from Berlin to Sydney
  3. Opinion: Is a Clone Really Born at Age Zero?
  4. ADHD Linked to Structural Differences in the Brain
Business Birmingham